Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan Approves KM Biologics’ Smallpox Vaccine for Monkeypox
August 2, 2022
-
BUSINESS Shionogi Eyes PIII Topline Readout for COVID Pill in Aug-Sept., Sticks to H1 Approval Plan
August 2, 2022
-
REGULATORY KM Biologics’s Smallpox Vaccine in Line to Add Monkeypox Use
August 1, 2022
-
REGULATORY New Expert Panel to Issue Proposals for 2023, 2024 Price Revisions; Official Spearheading Debate Prods Industry to Speak Up
July 29, 2022
-
BUSINESS Takeda to Lift Restricted Shipments for Leuplin in September after Over 2 Years
July 29, 2022
-
BUSINESS Mochida to Quit Filgrastim Biosimilar as Repeated Price Cuts Made It Unprofitable
July 28, 2022
-
BUSINESS GSK Japan Foresees 5% Annual Growth by 2026: President Lirette
July 28, 2022
-
BUSINESS Horizon Japan Eager for Solo Sales of Its 1st Product as Tepezza Trial Likely to Wrap Up Next Year
July 27, 2022
-
ORGANIZATION Veterans’ Group Proposes Timely Drug Re-Pricing with Online Data, Reimbursement at Actual Purchase Prices
July 27, 2022
-
ORGANIZATION JPMA Delays Announcement of Drug Pricing Proposal
July 27, 2022
-
BUSINESS BMS Has High Hopes on Eliquis Follow-Up with Less Bleeding Risks as Patent Loss Looms
July 26, 2022
-
REGULATORY Japan Confirms 1st Monkeypox Case
July 26, 2022
-
COMMENTARY Govt Should Examine Challenges with Emergency Approval Scheme Exposed by Shionogi Pill Review
July 25, 2022
-
REGULATORY KM Biologics’s Smallpox Vaccine Up for Review for Monkeypox Use
July 25, 2022
-
BUSINESS Keytruda, Opdivo, Tagrisso Breach 100 Billion Yen Sales Mark in FY2021: Tally
July 22, 2022
-
BUSINESS Shionogi to Steadily Promote PIII Trial for COVID Pill after Approval Setback
July 22, 2022
-
REGULATORY Japan Again Takes Pass on Emergency Approval for Shionogi’s COVID Pill as Panels Nix Presumed Efficacy
July 21, 2022
-
REGULATORY MHLW Official Sees More “Specified Clinical Research” Data Used in Regulatory Submissions to Fill Industry-Academia Void
July 20, 2022
-
REGULATORY MHLW Eyes Expert Panel Launch This Summer for Drug Distribution and Pricing: Official
July 19, 2022
-
REGULATORY Japan Plans to Lower Minimum Age for Novavax Jab to 12
July 19, 2022
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…